Finario Blog

Capex Confidential: Pharma & Biotech

INSIDER PERSPECTIVES FOR CAPITAL INVESTMENT STAKEHOLDERS Regulatory scrutiny. Scientific breakthroughs. Market saturation in once-lucrative therapeutic areas. Few industries experience change at the velocity pharma and biotech do, and in 2026,

Read More »
Post-Completion Reviews: You Know You Want to Do Them … Here’s How

December 8 | 30-Minute Webinar/Demo

Most companies agree that post-completion reviews should be conducted on material projects, but many still struggle to make them happen. So what gets in the way? Explore the common barriers to PCR adoption, practical ways to overcome them, and a simple roadmap for making reviews a manageable part of your process and building a culture of continuous improvement.